Emergency Medicine
Critical Care
Emergency
High Evidence

Advanced Life Support - Adult

Adult Advanced Life Support provides the framework for managing cardiac arrest beyond basic CPR and AED use. ALS incorpo... ACEM Primary Written, ACEM Primary V

Updated 23 Jan 2026
48 min read

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • Cardiac arrest is immediately life-threatening - every minute without CPR decreases survival by 7-10%
  • Delay to defibrillation in shockable rhythms decreases survival by 3-4% per minute
  • Unwitnessed arrests with prolonged downtime have extremely poor prognosis
  • Always consider reversible causes (4Hs/4Ts) - failure to identify leads to treatment failure

Exam focus

Current exam surfaces linked to this topic.

  • ACEM Primary Written
  • ACEM Primary Viva
  • ACEM Fellowship Written
  • ACEM Fellowship OSCE

Linked comparisons

Differentials and adjacent topics worth opening next.

  • Cardiac Arrest - Adult
  • PEA and Asystole

Editorial and exam context

ACEM Primary Written
ACEM Primary Viva
ACEM Fellowship Written
ACEM Fellowship OSCE
Clinical reference article

Quick Answer

Critical: Advanced Life Support (ALS) for adult cardiac arrest follows the ARC/ANZCOR Guideline 11 algorithm, emphasising high-quality CPR, early defibrillation for shockable rhythms, and systematic consideration of reversible causes. Survival depends on the Chain of Survival: early recognition, early CPR, early defibrillation, and early advanced care with post-resuscitation optimisation.

Adult Advanced Life Support provides the framework for managing cardiac arrest beyond basic CPR and AED use. ALS incorporates advanced airway management, vascular access, pharmacotherapy, rhythm interpretation, and treatment of reversible causes. In Australia, out-of-hospital cardiac arrest (OHCA) affects 55-113 per 100,000 population annually, with survival to discharge of approximately 10-12%. The ARC/ANZCOR guidelines differ from AHA in several key areas, including adrenaline timing and algorithm structure. High-quality CPR (100-120/min, 5-6cm depth, full recoil, minimal interruptions) remains the cornerstone of successful resuscitation [1,2].


ACEM Exam Focus

Primary Exam Relevance

  • Anatomy: Cardiac anatomy (coronary circulation, conduction system), chest wall anatomy for CPR mechanics, airway anatomy for intubation
  • Physiology: Cardiac electrophysiology (action potentials, automaticity), oxygen-haemoglobin dissociation, acid-base balance during arrest, cerebral autoregulation
  • Pharmacology: Adrenaline (alpha and beta effects), amiodarone (class III antiarrhythmic), sodium bicarbonate, calcium chloride, magnesium
  • Pathology: Ischaemic myocardial injury, hypoxic brain injury, reperfusion injury

Fellowship Exam Relevance

  • Written (SAQ/MCQ): Algorithm knowledge, drug doses and timing, reversible causes, post-resuscitation care, ECMO criteria, prognostication
  • OSCE: Resuscitation leadership station (extremely high yield), team communication, breaking bad news post-arrest
  • Key domains tested: Medical Expert (algorithm adherence), Leader (team coordination), Communicator (closed-loop, family communication)
  • Hot topics: ECPR eligibility, double sequential defibrillation, targeted temperature management controversy

Exam Discrimination Points

  • ARC algorithm timing differs from AHA - know Australian guidelines
  • Adrenaline: after 3rd shock (shockable), immediately (non-shockable)
  • Amiodarone dosing: 300mg then 150mg (not 150mg then 150mg)
  • ETCO2 interpretation during arrest
  • ECPR indications and contraindications

Key Points

Clinical Pearl

The 7 things you MUST know for ACEM:

  1. ARC/ANZCOR algorithm differs from AHA - adrenaline after 3rd shock (not 2nd) in shockable rhythms
  2. CPR quality metrics: Rate 100-120/min, depth 5-6cm, full recoil, minimal interruptions (under 10 sec)
  3. Adrenaline: 1mg IV every 3-5 minutes; after 3rd shock for shockable, immediately for non-shockable
  4. Amiodarone: 300mg after 3rd shock, 150mg after 5th shock for refractory VF/pVT
  5. 4Hs and 4Ts: Systematically consider reversible causes throughout resuscitation
  6. Shockable vs non-shockable: VF/pVT (shock + delayed adrenaline) vs PEA/asystole (immediate adrenaline, no shock)
  7. Post-ROSC: Avoid hyperoxia (SpO2 94-98%), maintain normocapnia, targeted temperature management, emergent angiography for STEMI

Epidemiology

MetricValueSource
OHCA incidence (Australia)55-113 per 100,000/year[3]
IHCA incidence1-6 per 1000 hospital admissions[4]
OHCA survival to discharge10-12%[5]
IHCA survival to discharge15-25%[6]
Initial shockable rhythm (OHCA)20-25%[7]
Bystander CPR rate (Australia)40-60%[8]
Public AED use5-10% of OHCA[9]
Survival with bystander CPR + AED50-70% (witnessed VF)[10]

Australian/NZ Specific Data

  • Aus-ROC Registry: National OHCA outcomes registry tracking approximately 20,000 cases annually [11]
  • Indigenous populations: 2-3x higher OHCA incidence, younger age at arrest, lower survival rates [12]
  • Metropolitan vs rural: Significant outcome disparity - metro survival 12%, rural 6-8% [13]
  • Public AED programs: Increasing but variable coverage; higher in metro areas [9]
  • RFDS coverage: Critical for remote areas; prolonged transport times affect viability
  • Bystander CPR rates increasing (30% in 2010 to 55% in 2023) [8]
  • Shockable rhythm proportion declining (35% in 2000 to 20% in 2023) [7]
  • Overall survival improving despite declining shockable rhythms [5]
  • COVID-19 pandemic: Transient decrease in bystander CPR and survival [14]

Pathophysiology

Mechanism of Cardiac Arrest

Electrical vs Mechanical Causes:

  • Shockable rhythms (VF/pVT): Primary electrical disturbance; cardiac muscle capable of coordinated contraction if rhythm restored
  • Non-shockable rhythms (PEA/Asystole): Usually metabolic, mechanical, or hypoxic cause; worse prognosis as underlying cause often irreversible

Phases of Cardiac Arrest

1. Electrical Phase (0-4 minutes)

  • Immediate VF may respond to defibrillation alone
  • Highest probability of successful conversion
  • Minimal ischaemic injury
  • CPR not essential if defibrillation immediate

2. Circulatory Phase (4-10 minutes)

  • ATP depleted, myocardium ischaemic
  • CPR essential before defibrillation (controversial)
  • Coronary perfusion required for shock success
  • Brain tolerating hypoxia but injury beginning

3. Metabolic Phase (greater than 10 minutes)

  • Systemic ischaemia-reperfusion injury
  • Multi-organ dysfunction developing
  • Coagulopathy, acidosis, hypothermia
  • Inflammatory cascade activation
  • Irreversible neuronal injury progressing

Physiology of CPR

Cardiac Pump Theory:

  • Direct cardiac compression between sternum and spine
  • Generates forward flow through valves
  • Produces approximately 25-30% normal cardiac output

Thoracic Pump Theory:

  • Intrathoracic pressure changes
  • Venous collapse prevents retrograde flow
  • Arterial flow maintained during compression

Coronary Perfusion Pressure (CPP):

  • CPP = Aortic diastolic pressure - Right atrial diastolic pressure
  • Target: greater than 15-20 mmHg for ROSC probability
  • Interrupted CPR causes CPP to drop rapidly
  • Requires 30+ seconds of compressions to rebuild

End-Tidal CO2 Physiology

During Arrest:

  • ETCO2 reflects pulmonary blood flow (cardiac output from CPR)
  • Low ETCO2 (under 10 mmHg): Poor CPR quality OR poor prognosis
  • ETCO2 10-20 mmHg: Adequate CPR, uncertain prognosis
  • Sudden rise during CPR: Suggests ROSC (increased pulmonary blood flow)

Prognostic Value:

  • ETCO2 persistently under 10 mmHg after 20 minutes: Very poor prognosis [15]
  • ETCO2 cannot differentiate good vs poor CPR in all cases
  • Affected by ventilation rate, sodium bicarbonate, pulmonary pathology

ARC/ANZCOR ALS Algorithm (Guideline 11)

Complete ANZCOR Guideline 11 Algorithm

┌─────────────────────────────────────────────────────────────────┐
│                    ADULT CARDIAC ARREST                         │
│                    ANZCOR Guideline 11                          │
└─────────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────────┐
│           CONFIRM CARDIAC ARREST                                 │
│  • Unresponsive                                                 │
│  • Not breathing normally (agonal gasps = arrest)               │
│  • No pulse (under 10 seconds check for healthcare providers)   │
└─────────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────────┐
│              CALL FOR HELP                                       │
│  • Call 000 (Australia) / 111 (New Zealand)                     │
│  • Activate hospital resuscitation team                         │
│  • Request defibrillator/AED                                    │
└─────────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────────┐
│           START HIGH-QUALITY CPR                                 │
│  • Rate: 100-120 compressions/minute                            │
│  • Depth: 5-6 cm (adult)                                        │
│  • Full chest recoil between compressions                       │
│  • Minimise interruptions (under 10 seconds)                    │
│  • 30:2 ratio (or continuous with advanced airway)              │
└─────────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────────┐
│           ATTACH DEFIBRILLATOR/MONITOR                          │
│  • Apply pads - anterior-lateral position                       │
│  • Analyse rhythm                                               │
└─────────────────────────────────────────────────────────────────┘
                              │
                              ▼
                    ┌─────────────────────┐
                    │   RHYTHM CHECK      │
                    │   (every 2 min)     │
                    └─────────────────────┘
                              │
              ┌───────────────┴───────────────┐
              ▼                               ▼
    ┌─────────────────┐              ┌─────────────────┐
    │   SHOCKABLE     │              │  NON-SHOCKABLE  │
    │   (VF / pVT)    │              │  (PEA/Asystole) │
    └─────────────────┘              └─────────────────┘
              │                               │
              ▼                               ▼
    ┌─────────────────┐              ┌─────────────────┐
    │  DEFIBRILLATE   │              │  ADRENALINE     │
    │  Biphasic:      │              │  1mg IV/IO      │
    │  150-200J       │              │  IMMEDIATELY    │
    │  (or as per     │              │  Then every     │
    │  device)        │              │  3-5 minutes    │
    │  Monophasic:    │              │                 │
    │  360J           │              │                 │
    └─────────────────┘              └─────────────────┘
              │                               │
              ▼                               ▼
    ┌─────────────────┐              ┌─────────────────┐
    │  RESUME CPR     │              │  RESUME CPR     │
    │  IMMEDIATELY    │              │  FOR 2 MINUTES  │
    │  for 2 minutes  │              │                 │
    └─────────────────┘              └─────────────────┘
              │                               │
              ▼                               │
    ┌─────────────────┐                       │
    │ After 3rd SHOCK │                       │
    │                 │                       │
    │ • Adrenaline    │                       │
    │   1mg IV/IO     │                       │
    │                 │                       │
    │ • Amiodarone    │                       │
    │   300mg IV/IO   │                       │
    └─────────────────┘                       │
              │                               │
              ▼                               │
    ┌─────────────────┐                       │
    │ After 5th SHOCK │                       │
    │                 │                       │
    │ • Amiodarone    │                       │
    │   150mg IV/IO   │                       │
    └─────────────────┘                       │
              │                               │
              └───────────────┬───────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────────┐
│              DURING CPR - THROUGHOUT                             │
│                                                                  │
│  • Ensure high-quality CPR: rate, depth, recoil                 │
│  • Rotate compressors every 2 minutes                           │
│  • Establish IV/IO access                                       │
│  • Consider advanced airway (do not interrupt CPR)              │
│  • Continuous waveform capnography                              │
│  • Treat REVERSIBLE CAUSES                                       │
│                                                                  │
│     4 Hs                        4 Ts                            │
│     ─────                       ─────                           │
│     Hypoxia                     Tension pneumothorax            │
│     Hypovolaemia                Tamponade                       │
│     Hypo/Hyperkalaemia          Toxins                          │
│     Hypothermia                 Thrombosis (PE/coronary)        │
│                                                                  │
│  • Consider ultrasound during rhythm check                      │
│  • Consider mechanical CPR for transport/interventions          │
│  • Consider ECMO/ECPR if appropriate                            │
└─────────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────────┐
│                         ROSC?                                    │
└─────────────────────────────────────────────────────────────────┘
                              │
              ┌───────────────┴───────────────┐
              ▼                               ▼
         ┌────────┐                    ┌─────────────┐
         │  YES   │                    │     NO      │
         └────────┘                    └─────────────┘
              │                               │
              ▼                               ▼
    ┌─────────────────┐              ┌─────────────────┐
    │ POST-ROSC CARE  │              │ CONTINUE CPR    │
    │                 │              │ OR              │
    │ • ABCDE         │              │ CONSIDER        │
    │ • SpO2 94-98%   │              │ TERMINATION     │
    │ • 12-lead ECG   │              │                 │
    │ • Treat cause   │              │ Termination     │
    │ • Target temp   │              │ criteria:       │
    │   management    │              │ • Asystole over 20  │
    │ • ICU admission │              │   min with ALS  │
    │                 │              │ • No reversible │
    │ STEMI? →        │              │   cause         │
    │ Emergent PCI    │              │ • ETCO2 below 10     │
    │                 │              │   persistently  │
    └─────────────────┘              └─────────────────┘

Shockable Rhythms Pathway (VF/pVT)

Ventricular Fibrillation (VF)

  • Definition: Chaotic, disorganised ventricular electrical activity without coordinated contraction
  • ECG appearance: Irregular, chaotic waveform; no identifiable P waves, QRS, or T waves
  • Coarse vs Fine VF: Amplitude greater than 0.5mV (coarse) vs less than 0.5mV (fine); coarse may respond better to defibrillation
  • Primary VF: Occurs as initial rhythm; better prognosis (typically ischaemic)
  • Secondary VF: Develops during resuscitation; often indicates deterioration

Pulseless Ventricular Tachycardia (pVT)

  • Definition: Wide complex tachycardia without palpable pulse
  • ECG appearance: Regular, wide QRS (greater than 120ms), rate usually 150-250/min
  • Monomorphic vs Polymorphic: Uniform QRS morphology (monomorphic) vs varying morphology (polymorphic/Torsades)
  • Treatment identical to VF: Defibrillation + ALS algorithm

Defibrillation Protocol

Energy Levels (ARC/ANZCOR):

Device Type1st ShockSubsequent Shocks
Biphasic (truncated exponential)150J150-200J
Biphasic (rectilinear)120J150-200J
Monophasic360J360J
AEDDevice-selectedDevice-selected

Defibrillation Technique:

  1. Charge during CPR (minimise hands-off time)
  2. "Stand clear"
  • visual and verbal confirmation
  1. Deliver shock
  2. Immediately resume CPR - do not check rhythm/pulse
  3. CPR for 2 minutes then rhythm check

Pad Position Options:

PositionDescriptionUse
Anterior-lateral (standard)Right infraclavicular + left lateral chestDefault position
Anterior-posteriorSternum + left infrascapularRefractory VF, pacemaker
Bi-axillaryBoth mid-axillary linesAlternative

Shockable Rhythm Timeline

TimeAction
0 minConfirm arrest, start CPR, attach monitor
~1 min1st shock (if VF/pVT) → Immediate CPR
2 minRhythm check → 2nd shock if still VF/pVT → CPR
4 minRhythm check → 3rd shock → Adrenaline 1mg + Amiodarone 300mg → CPR
6 minRhythm check → 4th shock → CPR
8 minRhythm check → 5th shock → Adrenaline 1mg + Amiodarone 150mg → CPR
10+ minContinue cycle: Shock → CPR 2 min → Adrenaline every 3-5 min

Refractory VF Strategies

If VF persists after 3+ shocks:

  1. Verify pad position and contact
  2. Change pad position (anterior-posterior)
  3. Double sequential defibrillation (off-label but emerging evidence) [16]
  4. Review reversible causes - especially electrolytes, toxins
  5. Consider thrombolysis if PE or STEMI suspected [17]
  6. Consider ECMO/ECPR if available and appropriate [18]
  7. Lignocaine 1-1.5mg/kg as alternative antiarrhythmic [19]

Non-Shockable Rhythms Pathway (PEA/Asystole)

Pulseless Electrical Activity (PEA)

  • Definition: Organised electrical activity on monitor without palpable pulse/cardiac output
  • Wide complex PEA: Usually indicates myocardial damage/dysfunction
  • Narrow complex PEA: May indicate mechanical cause (PE, tamponade, hypovolaemia)
  • Pseudo-PEA: Organised rhythm with some cardiac contraction but output insufficient for palpable pulse; may respond to vasopressors

Asystole

  • Definition: Complete absence of ventricular electrical activity
  • ECG appearance: Flat line (must confirm in 2 leads, check connections)
  • Fine VF vs Asystole: If uncertain, treat as VF (shock if any doubt)
  • Prognosis: Worst arrest rhythm; less than 5% survival if initial rhythm

Key Management Differences from Shockable

AspectShockable (VF/pVT)Non-Shockable (PEA/Asystole)
DefibrillationYes - every 2 minNo
Adrenaline timingAfter 3rd shockImmediately
AmiodaroneYes (300mg + 150mg)No
FocusRhythm terminationReversible cause treatment
PrognosisBetter (20-40% ROSC)Worse (5-15% ROSC)

PEA Reversible Causes - Focused Approach

Think "Cardiac Ultrasound" during rhythm check:

  • Tamponade: Pericardial fluid, RV collapse
  • PE: Dilated RV, D-sign
  • Hypovolaemia: Empty hyperdynamic LV
  • Wall motion abnormality: Ischaemia

Management by Cause:

Suspected CauseImmediate Action
HypovolaemiaAggressive fluid, blood products, surgery
Tension pneumothoraxFinger thoracostomy
TamponadePericardiocentesis, thoracotomy
Massive PEThrombolysis, ECMO
HyperkalaemiaCalcium chloride, insulin/dextrose

Drug Protocols

Adrenaline (Epinephrine)

Pharmacology:

  • Non-selective alpha and beta adrenergic agonist
  • Alpha-1: Peripheral vasoconstriction → increased coronary and cerebral perfusion pressure
  • Beta-1: Increased heart rate and contractility (less relevant during arrest)
  • Half-life: approximately 2 minutes

Dosing Protocol:

ParameterAdultNotes
Dose1mg (10mL of 1:10,000)Fixed dose in adults
RouteIV or IOPeripheral IV acceptable if running
Timing (shockable)After 3rd shockThen every 3-5 minutes
Timing (non-shockable)ImmediatelyThen every 3-5 minutes
Concentration1:10,000 (0.1mg/mL)Pre-filled syringes preferred

Evidence:

  • PARAMEDIC2 trial: Adrenaline improves ROSC (23.8% vs 8.0%) but no difference in favourable neurological outcome (2.2% vs 1.9%) [20]
  • Role increasingly questioned but remains standard of care
  • Earlier administration associated with better outcomes in observational studies [21]

Amiodarone

Pharmacology:

  • Class III antiarrhythmic (potassium channel blocker)
  • Also has sodium, calcium channel and beta-blocking properties
  • Long half-life (40-55 days)

Dosing Protocol:

ParameterAdultNotes
1st dose300mg IV/IOAfter 3rd shock for VF/pVT
2nd dose150mg IV/IOAfter 5th shock if refractory
DilutionCan give undiluted in arrestDilute for infusion post-ROSC
Max total450mg during arrestAdditional dosing post-ROSC

Evidence:

  • ALPS trial: No survival benefit vs lignocaine vs placebo [19]
  • Remains standard as may improve ROSC
  • Consider for refractory VF

Lignocaine (Alternative)

ParameterAdultNotes
Dose1-1.5 mg/kg IV/IOAlternative if amiodarone unavailable
Repeat0.5-0.75 mg/kgEvery 5-10 minutes
Max3 mg/kgTotal dose

Other Cardiac Arrest Drugs

DrugDoseIndicationNotes
Sodium bicarbonate1 mmol/kg (8.4%)pH less than 7.1, hyperkalaemia, tricyclic ODNot routine; may worsen intracellular acidosis
Calcium chloride10mL 10% (6.8 mmol Ca2+)Hyperkalaemia, hypocalcaemia, Ca-blocker OD, hypermagnesaemiaSlow IV push
Calcium gluconate30mL 10% (6.8 mmol Ca2+)As above (less irritant)Slower onset than chloride
Magnesium5 mmol (2.5g) IVTorsades de pointes, hypomagnesaemia, digoxin toxicityOver 1-2 min
AtropineNO LONGER recommendedPreviously used for asystole/PEARemoved from ALS algorithm
VasopressinNOT in ARC guidelinesAlternative to adrenaline (AHA)Not standard in Australia

Important: Atropine is NO LONGER part of the ARC/ANZCOR adult cardiac arrest algorithm. It was removed in 2010 as evidence showed no benefit in asystole or PEA. However, atropine remains useful for symptomatic bradycardia.


Advanced Airway Management

Airway Approach During Cardiac Arrest

Hierarchy of Priorities:

  1. High-quality CPR with minimal interruptions
  2. Basic airway manoeuvres (head tilt, chin lift, jaw thrust)
  3. Basic adjuncts (OPA, NPA)
  4. Bag-mask ventilation with two-person technique
  5. Supraglottic airway (SGA) device
  6. Endotracheal intubation (by experienced provider)

Key Principle: Do NOT interrupt CPR for intubation

Bag-Mask Ventilation (BVM)

Technique:

  • Two-person technique preferred
  • C-E grip for mask seal
  • Rate: 10 breaths/minute (1 every 6 seconds with advanced airway)
  • Avoid hyperventilation (reduces venous return)

Effectiveness:

  • PART trial: BVM equivalent to ETT for survival [22]
  • Reasonable first-line approach
  • Avoids intubation complications

Supraglottic Airways

DeviceAdvantagesDisadvantages
i-gelEasy insertion, no cuff inflationSingle use, sizing required
LMA SupremeGastric channel, familiarCuff inflation needed
Laryngeal tubeEasy, quickLess familiar to some

SGA Evidence:

  • AIRWAYS-2 trial: SGA non-inferior to ETT for 30-day survival [23]
  • Consider as first-line advanced airway
  • Faster insertion, fewer interruptions

Endotracheal Intubation

Indications During Arrest:

  • Inadequate oxygenation with BVM/SGA
  • High aspiration risk
  • Prolonged resuscitation expected
  • Post-ROSC if ongoing airway concern

Technique in Arrest:

  1. Prepare equipment during CPR (ETT, laryngoscope, drugs not usually needed)
  2. Pre-oxygenate (if possible)
  3. Attempt intubation during 10-second pause for rhythm check
  4. If unsuccessful in 30 seconds, resume CPR with BVM/SGA
  5. Confirm with waveform capnography

Confirmation:

  • Waveform capnography - Gold standard
  • Clinical: Chest rise, breath sounds, misting
  • Do not rely on oesophageal detector alone

Ventilation with Advanced Airway

ParameterTarget
Rate10 breaths/minute
Tidal volumeVisible chest rise
FiO2100% during arrest
Pause for ventilationNot required - continuous compressions

Capnography Targets:

ETCO2Interpretation
Under 10 mmHgPoor CPR quality or poor prognosis
10-20 mmHgAdequate CPR
Greater than 20 mmHgGood CPR or ROSC
Sudden riseLikely ROSC

Vascular Access

Intravenous Access

Preferred Sites:

  1. Antecubital fossa (most accessible during CPR)
  2. External jugular vein
  3. Femoral vein (if experienced)

Considerations:

  • Peripheral IV acceptable - follow with 20mL flush
  • Do not interrupt CPR for IV access
  • If IV unsuccessful after 2 attempts, proceed to IO

Intraosseous Access

Indications:

  • IV access unsuccessful within 60-90 seconds
  • Difficult venous access anticipated
  • Time-critical situation

Sites:

SiteAdvantagesDisadvantages
Proximal tibiaEasy landmark, low complicationLeg movement during CPR
Proximal humerusFast drug deliveryInterferes with compressions
Distal tibiaAlternativeSmaller cavity
SternumDirect central deliverySpecial device needed

Devices Available:

  • EZ-IO (battery-powered drill)
  • FAST1 (sternal)
  • Manual IO needles

Drug Delivery:

  • All resuscitation drugs can be given IO
  • Equivalent efficacy to IV
  • Flush with 10-20mL saline after each drug

Endotracheal Drug Administration

Not recommended in current guidelines

Previously used for adrenaline, atropine, lignocaine, naloxone (ALAN) when IV/IO unavailable.

Reasons for removal:

  • Unreliable absorption
  • Lower plasma levels
  • IO access readily available
  • May worsen outcomes

Rhythm Recognition

Four Arrest Rhythms

1. Ventricular Fibrillation (VF)

ECG Features:
• Chaotic, irregular waveform
• No identifiable P, QRS, or T waves
• Variable amplitude (coarse vs fine)
• Rate not measurable

Action: SHOCK + ALS algorithm

2. Pulseless Ventricular Tachycardia (pVT)

ECG Features:
• Wide QRS (greater than 120ms)
• Regular rhythm
• Rate 150-250/min
• No pulse palpable

Action: SHOCK + ALS algorithm (treat as VF)

3. Pulseless Electrical Activity (PEA)

ECG Features:
• Organised electrical activity
• May be narrow or wide complex
• May look "normal" sinus rhythm
• NO PULSE

Action: CPR + Adrenaline immediately + Treat cause

4. Asystole

ECG Features:
• Flat line (no electrical activity)
• May see P waves only (ventricular standstill)
• Confirm in 2 leads
• Check connections/gain

Action: CPR + Adrenaline immediately + Treat cause

Rhythm Check Protocol

10-Second Pause Every 2 Minutes:

  1. Pause compressions
  2. Assess rhythm on monitor
  3. Pulse check only if organised rhythm
  4. Charge defibrillator during pause if shockable
  5. Resume CPR immediately (or shock then CPR)

Common Errors:

  • Prolonged rhythm checks (greater than 10 seconds)
  • Checking pulse for VF (unnecessary)
  • Mistaking fine VF for asystole (if in doubt, shock)
  • Not confirming asystole in second lead

Reversible Causes (4Hs and 4Ts)

Systematic Approach

Consider reversible causes throughout resuscitation, not just when initial rhythm fails to convert

4 Hs

CauseRecognitionTreatmentNotes
HypoxiaHistory (choking, asthma, drowning), cyanosis, SpO2Oxygenation, secure airway, treat underlying causeMost common cause in non-cardiac arrest
HypovolaemiaTrauma, GI bleed, ruptured AAA, obstetric haemorrhageAggressive fluid, blood products, surgical controlUltrasound shows empty hyperdynamic heart
Hypo/HyperkalaemiaRenal disease, dialysis, medications, ECG changesCalcium chloride 10mL 10%; Insulin/dextrose; DialysisVBG for K+ during arrest
HypothermiaEnvironmental exposure, drowning, elderlyActive rewarming, continue CPR until warm (32 degrees C)"Not dead until warm and dead"

4 Ts

CauseRecognitionTreatmentNotes
Tension pneumothoraxTrauma, positive pressure ventilation, absent breath sounds, tracheal deviationFinger/needle thoracostomy immediatelyDo not wait for CXR; clinical diagnosis
TamponadePenetrating trauma, post-MI, pericarditis, muffled sounds, PEAPericardiocentesis, emergency thoracotomyUltrasound during rhythm check
ToxinsHistory, toxidrome, medication bottles, pupilsSpecific antidotes (lipid emulsion, glucagon, digoxin-Fab, naloxone)Contact Poisons Information Centre 13 11 26
Thrombosis (PE)Immobility, malignancy, recent surgery, RV strain on echoThrombolysis (50mg alteplase bolus), ECMOConsider empiric thrombolysis for massive PE
Thrombosis (Coronary)Cardiac history, prodromal chest pain, ECG changesMechanical CPR + emergent PCI, thrombolysis if PCI unavailableSTEMI on 12-lead → cath lab

Ultrasound in Cardiac Arrest

During Rhythm Check (10 seconds):

  • Subxiphoid or parasternal view
  • Assess for:
    • Cardiac activity (pseudo-PEA if contracting)
    • Pericardial effusion (tamponade)
    • RV dilation (PE)
    • Hypovolaemia (empty LV)

Limitations:

  • Requires skilled operator
  • May prolong pause if not rapid
  • Should not delay interventions

CPR Quality Metrics

Compression Parameters

ParameterTargetRationale
Rate100-120/minOptimal coronary perfusion
Depth5-6 cmAdequate cardiac output
RecoilCompleteAllows venous return
InterruptionsUnder 10 secondsMaintains CPP
Chest compression fractionGreater than 60% (aim greater than 80%)More time compressing
RotationEvery 2 minutesPrevents fatigue

Quality Monitoring

MetricTargetClinical Meaning
ETCO2Greater than 10 mmHgAdequate CPR quality
ETCO2Greater than 20 mmHgGood perfusion
ETCO2 sudden riseGreater than 40 mmHgLikely ROSC
Arterial waveformPresent during CPRAdequate compressions

Mechanical CPR Devices

Indications:

  • Transport during arrest
  • Prolonged resuscitation
  • PCI during arrest
  • Limited personnel

Evidence:

  • LINC and PARAMEDIC trials: No survival benefit over manual CPR [24,25]
  • Role is to maintain consistency during transport/procedures

Special Circumstances

Pregnancy

Key Modifications:

AspectModificationRationale
PositioningManual left uterine displacement (not tilt)Relieves aortocaval compression
CompressionsSlightly higher on sternumElevated diaphragm
AirwayEarly intubation consideredHigher aspiration risk, difficult airway
Perimortem CSBy 5 minutes if no ROSCImproves maternal and foetal outcomes
DrugsStandard dosesNo modification needed

Perimortem Caesarean Section:

  • Begin at 4 minutes of arrest
  • Complete by 5 minutes
  • Improves venous return for mother
  • May save viable foetus (greater than 23 weeks)
  • Perform in resuscitation bay
  • Continue CPR during procedure

Drowning

Key Modifications:

AspectModificationRationale
Initial ventilation5 rescue breaths firstHypoxia is primary cause
CPR ratioStandard 30:2After initial breaths
HypothermiaCommon - prolonged resuscitationCold water protective
C-spineImmobilisation if diving/trauma suspectedLow incidence if no trauma history

Electrocution

Key Points:

  • May cause VF or asystole
  • Scene safety paramount
  • Burns may indicate current path
  • Myocardial injury common
  • Standard ALS algorithm
  • Monitor for arrhythmias post-ROSC

Hypothermia

Definitions:

SeverityCore TemperatureManagement
Mild32-35 degrees CPassive rewarming
Moderate28-32 degrees CActive external rewarming
SevereUnder 28 degrees CActive internal rewarming

Key Modifications:

  • Continue CPR until core temp greater than 32 degrees C (or greater than 35 degrees C if ECMO available)
  • Withhold drugs if temp less than 30 degrees C (delayed metabolism)
  • Space drugs at longer intervals (6-10 min) if 30-35 degrees C
  • Single shock reasonable; if VF refractory, defer further shocks until greater than 30 degrees C
  • Consider ECMO for severe hypothermic arrest

Anaphylaxis Cardiac Arrest

Key Points:

  • Adrenaline 1mg IV (same as standard arrest)
  • Large volume fluid (anaphylaxis is distributive + hypovolaemic)
  • Consider adrenaline infusion post-ROSC
  • Prolonged CPR may be successful
  • Glucagon if on beta-blockers

Asthma Cardiac Arrest

Key Points:

  • Usually PEA or asystole (hypoxia, tension pneumothorax)
  • Bilateral finger thoracostomies early
  • Disconnect ventilator (auto-PEEP may impair venous return)
  • Allow prolonged expiration
  • Consider IV salbutamol, magnesium
  • Higher ROSC rates with aggressive treatment

Poisoning/Overdose

Specific Antidotes:

ToxinAntidoteDose
OpioidsNaloxone0.4-2mg IV (may need repeat)
Beta-blockersGlucagon5-10mg IV bolus
Calcium channel blockersCalcium chloride + High-dose insulinCaCl2 10mL + Insulin 1 unit/kg
TricyclicsSodium bicarbonate1-2 mEq/kg IV
Local anaestheticsIntralipid 20%1.5 mL/kg bolus then infusion
DigoxinDigoxin-FabEmpiric 10 vials if life-threatening

Team Dynamics and CRM (Crisis Resource Management)

Resuscitation Team Roles

RoleResponsibilitiesPosition
Team LeaderOverall coordination, decision-making, algorithm, dispositionFoot of bed (overview)
AirwayBVM ventilation, intubation, airway adjunctsHead of bed
CompressionsHigh-quality CPR, rotation every 2 minSide of chest
DefibrillatorRhythm analysis, shock delivery, pad positionSide of chest
Access/DrugsIV/IO access, medication preparation/administrationAccessible IV site
ScribeTime-keeping, documentation, promptingVisible position

Closed-Loop Communication

Structure:

  1. Leader gives order: "Give adrenaline 1mg IV now"
  2. Team member confirms: "Adrenaline 1mg IV, giving now"
  3. Team member completes and reports: "Adrenaline 1mg given"

Benefits:

  • Ensures message received
  • Confirms task completion
  • Reduces errors

Team Leader Best Practices

Before Arrest (if possible):

  • Brief team on roles
  • Ensure equipment checked
  • Identify expertise levels

During Arrest:

  • Stand back - maintain situational awareness
  • Avoid performing procedures (delegate)
  • Verbalise thinking ("Rhythm check shows VF, we will shock")
  • Summarise regularly ("This is a 55-year-old male, 4 shocks given, adrenaline x2...")
  • Invite input ("Anyone see anything I'm missing?")

Common Team Leader Errors:

  • Getting "hands on" and losing oversight
  • Tunnel vision on one task
  • Not rotating compressors
  • Forgetting to consider reversible causes
  • Inadequate communication

Quality Metrics to Verbalise

MetricTargetPrompt
Compression rate100-120/min"Rate check - are we in range?"
Compression depth5-6 cm"Full depth compressions"
Chest recoilComplete"Full recoil between compressions"
InterruptionsUnder 10 sec"Minimise hands-off time"
ETCO2Greater than 10 mmHg"What's our ETCO2?"
Time to shockMinimise"Charging during compressions"

Post-Resuscitation Care

Immediate Post-ROSC (First 20 Minutes)

ABCDE Approach:

A - Airway:

  • Confirm ETT position (waveform capnography)
  • If no advanced airway, secure if needed
  • Suction as required

B - Breathing:

ParameterTargetRationale
SpO294-98%Avoid hyperoxia (oxidative injury)
PaCO235-45 mmHg (4.5-6.0 kPa)Avoid hypo/hypercapnia
FiO2Titrate down from 100%Once SpO2 stable
Ventilation10-12 breaths/minAvoid hyperventilation

C - Circulation:

ParameterTargetManagement
MAPGreater than 65-70 mmHgFluids, vasopressors (noradrenaline)
Heart rateAvoid extremesRate control if rapid AF, pacing if severe bradycardia
ECG12-lead STATSTEMI → emergent angiography
LactateTrend downMarker of perfusion

D - Disability:

  • GCS assessment (note may be sedated/paralysed)
  • Pupil size and reactivity
  • Blood glucose (target 7.8-10 mmol/L)
  • Seizure management (common post-arrest)
  • Avoid hyperthermia (37.5 degrees C or less)

E - Exposure:

  • Core temperature
  • Identify cause (look for clues)
  • Injuries from CPR

Targeted Temperature Management (TTM)

Current ARC/ANZCOR Recommendations:

  • Maintain constant temperature 32-36 degrees C for at least 24 hours
  • TTM-2 trial: No benefit of 33 degrees C vs normothermia (37.5 degrees C or less) [26]
  • Avoid fever (temp greater than 37.7 degrees C) for at least 72 hours
  • Rewarming: 0.25-0.5 degrees C per hour (slow)

Methods:

MethodAdvantagesDisadvantages
Surface cooling (blankets)Non-invasive, widely availableSlower, shivering
Intravascular catheterPrecise controlInvasive, expensive
Cold IV fluidsRapid, availableLimited effect alone

Complications of Hypothermia:

  • Shivering (treat with sedation, paralysis)
  • Bradycardia (usually well-tolerated)
  • Coagulopathy
  • Electrolyte shifts (K+ changes during rewarming)
  • Infection risk

STEMI Post-Arrest

Emergent Coronary Angiography Indications:

  • ST-elevation on post-ROSC ECG
  • High suspicion of coronary cause (witnessed VF, cardiac history)
  • Consider even without ST-elevation in comatose survivors [27]

Timing:

  • Immediate (under 2 hours) for STEMI
  • Early (within 24 hours) for high suspicion without STEMI

Neurological Prognostication

When to Prognosticate:

  • Minimum 72 hours after normothermia achieved
  • Do NOT prognosticate in first 24-48 hours
  • Multimodal approach essential

Prognostic Modalities:

ModalityPoor Prognosis IndicatorTiming
Clinical examAbsent pupillary/corneal reflexes72h or more after normothermia
SSEPBilaterally absent N2024h or more after normothermia
EEGBurst-suppression, status epilepticus24-72h or more
CT brainSevere diffuse oedema24h or more
MRI brainDiffuse cortical DWI restriction3-7 days
NSEGreater than 60 micrograms/L (highly specific)48-72h

Ethical Considerations:

  • Avoid self-fulfilling prophecy
  • Include family in discussions
  • Palliative care involvement if poor prognosis

ECMO/ECPR

Extracorporeal CPR (ECPR)

Definition: Initiation of extracorporeal membrane oxygenation (ECMO) during cardiac arrest when conventional ALS fails.

Indications for ECPR

Potential Candidates:

  • Witnessed arrest with good-quality bystander CPR
  • Initial shockable rhythm (VF/pVT)
  • Refractory VF (persists despite optimal ALS)
  • Age typically under 70 years (varies by centre)
  • No flow time under 5 minutes
  • Low flow time (CPR) under 60-90 minutes
  • Suspected reversible cause (PE, MI, hypothermia, toxins)

Contraindications:

  • Unwitnessed arrest with unknown downtime
  • Prolonged arrest (greater than 60-90 minutes) without good CPR quality
  • Terminal illness
  • Known severe neurological injury
  • Severe frailty
  • No consent/advance directive refusing

ECPR Evidence

  • ARREST trial: Improved survival with ECPR for refractory OHCA VF (43% vs 7%) [18]
  • Prague OHCA: ECPR improved survival with favourable neurological outcome (31% vs 22%) [28]
  • Requires established program with rapid deployment capability

Practical Considerations

Availability:

  • Metro tertiary centres only
  • Requires interventional cardiology, CT surgery, perfusion support
  • May require mechanical CPR for transport
  • Pre-hospital ECMO developing in some systems

Australian Landscape:

  • Available at major metropolitan centres
  • Not currently available in most regional/rural settings
  • Criteria vary by institution

Disposition

All ROSC Patients

  • 100% require ICU/HDU admission
  • No exception - all cardiac arrest survivors need critical care monitoring
  • Minimum 24-hour continuous monitoring
  • Specialist critical care input

Immediate Transfer Indications

IndicationDestination
STEMICardiac catheterisation laboratory (emergent PCI)
Massive PEInterventional radiology, ECMO, or cardiothoracic surgery
Refractory arrest + ECPR candidateECMO centre
Post-ROSC instabilityICU/CCU

Termination of Resuscitation

Consider Termination When:

  • Asystole persisting greater than 20 minutes despite ALS
  • ETCO2 persistently under 10 mmHg after 20 minutes [15]
  • All reversible causes addressed/excluded
  • No ROSC despite optimal resuscitation
  • Patient factors (advanced directive, terminal illness)

Universal TOR Rules for OHCA:

  1. Not witnessed by EMS
  2. No bystander CPR
  3. No shock delivered
  4. No ROSC before transport (All four = very high probability of death)

Factors Supporting Continued Resuscitation:

  • Witnessed arrest with short downtime
  • Initial shockable rhythm
  • Bystander CPR
  • Signs of life during CPR
  • Reversible cause not yet treated
  • Hypothermia
  • Young age
  • Good pre-arrest function

Documentation Requirements

  • Time of arrest recognition
  • CPR initiation time
  • Rhythm at each check
  • Shocks delivered (number, joules)
  • Medications given (drug, dose, time)
  • Interventions (airway, access)
  • ROSC time (or termination time and reason)
  • Quality metrics if monitored

Pitfalls and Pearls

Clinical Pearl

Clinical Pearls:

  • ETCO2 is your friend: Low ETCO2 (under 10 mmHg) indicates poor CPR quality or poor prognosis; sudden rise suggests ROSC before pulse palpable
  • Don't stop for intubation: BVM or SGA are acceptable; ETT does not improve survival
  • Bedside echo during rhythm check: Can identify reversible causes and pseudo-PEA in 10 seconds
  • Mechanical CPR enables transport: Consider for PCI, ECMO, or inter-hospital transfer
  • Refractory VF options: Change pad position, double sequential defibrillation, consider ECPR
  • Post-ROSC hyperoxia is harmful: Titrate FiO2 to SpO2 94-98%, not 100%
  • Potassium kills silently: Check VBG early for K+ in PEA/asystole
  • Pause wisely: Combine rhythm check + pulse check + echo in one 10-second pause
Red Flag

Pitfalls to Avoid:

  • Using AHA instead of ARC algorithm - adrenaline timing differs (after 3rd shock, not 2nd)
  • Interrupting CPR for greater than 10 seconds - CPP drops rapidly and takes time to rebuild
  • Giving adrenaline too early in shockable rhythms - wait until after 3rd shock
  • Hyperventilating - reduces venous return and coronary perfusion
  • Forgetting reversible causes - especially tension pneumothorax and hyperkalaemia
  • Terminating too early - ensure all Hs and Ts considered
  • Not rotating compressors - fatigue impairs CPR quality within 2 minutes
  • Checking pulse after shock - resume CPR immediately without pulse check
  • Using atropine - no longer in adult cardiac arrest algorithm
  • Hyperoxia post-ROSC - oxidative injury worsens neurological outcome

Viva Practice

Viva Scenario

Stem: You are the Emergency Registrar. Paramedics bring in a 58-year-old male in cardiac arrest. They have been performing CPR for 8 minutes and have delivered 2 shocks for VF en route. The rhythm on arrival is VF. You are the team leader.

Opening Question: Talk me through your approach.

Model Answer: "Thank you. I will assume the team leader role and position myself at the foot of the bed to maintain situational awareness.

First, I will confirm the arrest - the patient appears unresponsive and apnoeic. I will confirm the rhythm is VF on our monitor.

I will ensure high-quality CPR continues with rate 100-120/min, depth 5-6cm, and full chest recoil. I will ask someone to start the timer and document.

Since this is the 3rd rhythm analysis with VF, I will:

  1. Charge the defibrillator to 150-200J biphasic during CPR
  2. Deliver the 3rd shock after ensuring everyone is clear
  3. Immediately resume CPR for 2 minutes
  4. Give adrenaline 1mg IV and amiodarone 300mg IV now - as we're past the 3rd shock

During CPR, I will ensure IV access is confirmed and running. I will ask for end-tidal CO2 monitoring. I will delegate someone to prepare for an advanced airway if needed, but will not interrupt CPR for intubation.

I will systematically consider reversible causes - the 4Hs and 4Ts. Given his age and VF, I'm most concerned about coronary thrombosis. I would like a brief focused echo during the next rhythm check.

I will rotate compressors every 2 minutes to maintain CPR quality."

Follow-up Questions:

  1. "After your 5th shock, the rhythm changes to asystole. What do you do?"

    • Model answer: "Asystole is a non-shockable rhythm. I would continue CPR, give adrenaline 1mg immediately if not given recently, and aggressively search for and treat reversible causes. I would confirm asystole in two leads and check connections. I would continue the resuscitation and reassess in 2 minutes. Given the prolonged arrest with rhythm deterioration, I would also be preparing for difficult conversations with family if this continues."
  2. "Your ETCO2 has been 8 mmHg for the past 10 minutes. What does this mean?"

    • Model answer: "ETCO2 less than 10 mmHg is concerning. It either indicates poor CPR quality or is a poor prognostic sign. I would first assess CPR quality - are we achieving adequate rate, depth, and recoil? Are there adequate pauses for ventilation? I would rotate compressors immediately if not recently done. If CPR quality is confirmed adequate, persistently low ETCO2 is associated with very low probability of ROSC and may support a decision to terminate if other factors align."
  3. "The patient achieves ROSC. What are your immediate priorities?"

    • Model answer: "Post-ROSC, I would optimise using an ABCDE approach. Airway - confirm or secure the airway. Breathing - target SpO2 94-98%, reduce FiO2 to avoid hyperoxia, target normocapnia with PaCO2 35-45. Circulation - target MAP greater than 65, commence noradrenaline if hypotensive, obtain a 12-lead ECG looking for STEMI. Disability - note GCS, pupils, treat seizures, target normoglycaemia. I would initiate targeted temperature management and arrange ICU admission. If STEMI is present, I would contact cardiology for emergent angiography."

Discussion Points:

  • ARC vs AHA timing of adrenaline
  • Role of ECMO in refractory arrest
  • Prognostication after cardiac arrest
Viva Scenario

Stem: A 35-year-old female is brought in by ambulance in cardiac arrest. She was found collapsed at home. She has a history of depression and is on multiple medications. The rhythm is PEA with narrow complexes.

Opening Question: This is PEA. How does your approach differ from VF?

Model Answer: "PEA is a non-shockable rhythm, so my approach differs in several ways.

Firstly, I will not deliver shocks - they are not indicated for PEA. Secondly, I will give adrenaline 1mg IV immediately, not waiting for any shocks. I will continue adrenaline every 3-5 minutes. Amiodarone is not indicated.

The most important aspect of managing PEA is aggressive identification and treatment of reversible causes. Given this young woman with depression and medication access, I am highly suspicious of toxin ingestion. The narrow-complex PEA supports cardiac activity with a mechanical cause of cardiac output failure.

I would:

  1. Obtain history from paramedics - any pill bottles at scene, suicide note, recent stressors
  2. Examine for toxidrome - pupils, skin, temperature
  3. Get a VBG for potassium and pH
  4. Perform brief echo during rhythm check - looking for cardiac activity (pseudo-PEA), tamponade, or hypovolaemia
  5. Consider empiric treatment based on likely toxins

Common overdoses in this demographic include:

  • Tricyclic antidepressants - give sodium bicarbonate 1-2mmol/kg
  • Beta-blockers - glucagon 5-10mg, calcium, high-dose insulin
  • Calcium channel blockers - calcium chloride, high-dose insulin
  • Opioids - naloxone 0.4-2mg
  • Paracetamol - NAC if ingestion confirmed

I would contact the Poisons Information Centre (13 11 26) for advice."

Follow-up Questions:

  1. "Paramedics found empty bottles of amitriptyline. What is your management?"

    • Model answer: "Amitriptyline is a tricyclic antidepressant. TCA overdose causes sodium channel blockade (wide QRS, VT), anticholinergic toxicity, and alpha blockade. Management includes: sodium bicarbonate 1-2 mmol/kg IV boluses targeting QRS narrowing and pH 7.45-7.55; hyperventilation (contributes to alkalosis); consider intralipid 20% as a lipid sink; magnesium for arrhythmias; avoid Class Ia/Ic antiarrhythmics; avoid flumazenil if benzodiazepines also suspected. Prolonged CPR may be successful - TCA arrests can recover after extended resuscitation."
  2. "The patient remains in PEA after 25 minutes. When would you consider termination?"

    • Model answer: "In a young patient with a potentially reversible cause like TCA overdose, I would continue resuscitation longer than for typical medical arrests. Factors supporting continued resuscitation include: young age, witnessed/short downtime, potentially reversible cause (toxin), and the observation that TCA arrests can have late ROSC. I would terminate if: all reversible causes have been addressed, ETCO2 remains persistently low despite good CPR quality, we have administered aggressive antidotal therapy without response, and after discussion with toxicology. I would involve family in discussions if appropriate."

Discussion Points:

  • Toxicological causes of cardiac arrest
  • Intralipid therapy
  • Extended resuscitation for reversible causes
Viva Scenario

Stem: A 52-year-old male with no known medical history collapsed at the gym. He received immediate bystander CPR and an AED delivered 3 shocks before paramedics arrived. He has now received a total of 8 shocks, adrenaline x3, and amiodarone 300mg + 150mg. He remains in VF after 30 minutes of CPR.

Opening Question: This is refractory VF. What additional strategies would you consider?

Model Answer: "This is refractory ventricular fibrillation - VF that persists despite repeated shocks and antiarrhythmic therapy. My additional strategies include:

Optimising Defibrillation:

  1. Change pad position to anterior-posterior
  2. Consider double sequential defibrillation - using two defibrillators simultaneously (off-label but emerging evidence)
  3. Ensure adequate pad contact and gel

Additional Pharmacotherapy:

  1. Lignocaine 1-1.5 mg/kg IV as alternative antiarrhythmic
  2. Magnesium 5 mmol IV (even if not Torsades)
  3. Review reversible causes - especially electrolytes

Addressing Reversible Causes:

  1. This fit male at the gym with primary VF - highly suspicious for acute coronary syndrome
  2. Consider empiric thrombolysis if STEMI suspected and PCI unavailable
  3. POCUS looking for wall motion abnormalities

ECPR Consideration: This patient is an excellent candidate for ECMO:

  • Witnessed arrest
  • Immediate bystander CPR
  • Initial shockable rhythm
  • Age 52 (under 70)
  • No known comorbidities
  • Likely reversible cause (ACS)
  • Total CPR time 30 minutes (within window)

I would contact the ECMO team immediately. We need mechanical CPR for safe transport and catheterisation laboratory activation. The goal would be ECMO initiation with concurrent coronary angiography."

Follow-up Questions:

  1. "ECMO is not available at your hospital. What are your options?"

    • Model answer: "I would contact the nearest ECMO-capable centre for advice and potential retrieval. Options include: continuing conventional ALS while arranging transfer with mechanical CPR; administering thrombolysis if STEMI is suspected (50mg alteplase bolus); ensuring maximal conventional therapy; early discussion with family about prognosis if retrieval not feasible."
  2. "After 45 minutes of resuscitation, the patient achieves ROSC. What are your concerns?"

    • Model answer: "After prolonged resuscitation, my concerns include: severe hypoxic-ischaemic brain injury (main determinant of outcome); multi-organ dysfunction from ischaemia-reperfusion; coagulopathy; myocardial stunning and cardiogenic shock; metabolic derangements. Immediate priorities: aggressive post-ROSC care, likely inotropic/vasopressor support, emergent angiography for underlying ACS, targeted temperature management, and early ICU involvement. I would counsel family about guarded prognosis."

Discussion Points:

  • ECPR eligibility criteria
  • Double sequential defibrillation
  • Thrombolysis in cardiac arrest

OSCE Scenarios

Station 1: Resuscitation Leadership - VF Arrest

Format: Resuscitation leadership Time: 11 minutes Setting: ED resuscitation bay

Candidate Instructions:

You are the Emergency Registrar. A 62-year-old male has arrived by ambulance in cardiac arrest. Paramedics have been performing CPR for 6 minutes and have given 2 shocks for VF. The rhythm on the monitor is VF.

Lead the resuscitation. Your team consists of two nurses and one junior doctor.

The examiner will provide clinical information as the scenario progresses.

Examiner Instructions:

  • Rhythm sequence: VF → VF → VF → ROSC after 4th shock
  • Post-ROSC: BP 78/50, HR 110, SpO2 96% on 100% O2
  • 12-lead ECG: ST elevation in V1-V4
  • Provide information when requested; prompt if candidate delays

Actor/Team Brief:

  • Nurses competent but wait for instructions
  • Junior doctor can perform procedures if directed
  • Respond to closed-loop communication appropriately

Marking Criteria:

DomainCriterionMarks
LeadershipAssumes team leader role clearly, stands back/1
Role allocationAssigns specific roles to team members/1
AlgorithmFollows ARC ALS algorithm correctly/2
ShocksAppropriate energy, minimises pause/1
DrugsAdrenaline after 3rd shock, correct dose/1
DrugsAmiodarone 300mg after 3rd shock/1
Reversible causesConsiders 4Hs/4Ts systematically/1
CommunicationClosed-loop communication throughout/1
Post-ROSCABCDE approach, identifies STEMI, activates cath lab/2
TOTAL/11

Expected Standard:

  • Pass: 6/11 or greater
  • Key discriminators: ARC algorithm adherence (adrenaline timing), team leadership (not doing procedures), recognising and acting on STEMI

Station 2: Resuscitation Leadership - PEA with Reversible Cause

Format: Resuscitation leadership Time: 11 minutes Setting: ED resuscitation bay

Candidate Instructions:

You are the Emergency Registrar. A 45-year-old female who is 32 weeks pregnant has collapsed in the hospital corridor. CPR is in progress. The rhythm on the monitor shows organised electrical activity at 80bpm but there is no pulse.

Lead the resuscitation.

Examiner Instructions:

  • Initial rhythm: PEA
  • Without uterine displacement: Remains PEA
  • With uterine displacement: Achieves ROSC after 4 minutes
  • If candidate fails to apply uterine displacement, prompt at 4 minutes: "Is there anything specific about this patient that might affect your resuscitation approach?"

Marking Criteria:

DomainCriterionMarks
RecognitionIdentifies PEA as non-shockable/1
DrugsAdrenaline immediately, not after shocks/1
Pregnancy considerationRecognises pregnancy modifies resuscitation/1
Uterine displacementApplies manual left uterine displacement/2
Perimortem CSConsiders/discusses if no ROSC by 5 min/2
AlgorithmCorrect ALS approach for non-shockable/1
CommunicationClear team leadership/1
Post-ROSCAppropriate care including obstetric input/2
TOTAL/11

Expected Standard:

  • Pass: 6/11 or greater
  • Key discriminators: Recognising pregnancy modification, manual uterine displacement, mentioning perimortem caesarean section

SAQ Practice

Question 1 (6 marks)

Stem: A 58-year-old male collapses at home. His wife calls 000 and commences CPR as instructed by the dispatcher. Paramedics arrive within 8 minutes and find him in ventricular fibrillation. They defibrillate twice and transport to your ED with CPR in progress.

Question: List 6 key components of high-quality CPR according to ARC guidelines.

Model Answer:

  • Compression rate of 100-120 per minute (1)
  • Compression depth of 5-6 cm in adults (1)
  • Full chest recoil between compressions (1)
  • Minimise interruptions to under 10 seconds (1)
  • 30:2 compression to ventilation ratio (or continuous with advanced airway) (1)
  • Rotate compressors every 2 minutes to prevent fatigue (1)

Examiner Notes:

  • Accept: Avoid excessive ventilation, allow complete chest recoil, hard and fast
  • Also accept: Place heel of hand on lower half of sternum; avoid leaning on chest
  • Do not accept: Generic answers like "good compressions" without specifics

Question 2 (8 marks)

Stem: A 70-year-old female is in cardiac arrest with pulseless electrical activity (PEA). She has been receiving ALS for 15 minutes.

Question: (a) List 4 potential reversible causes from the "4 Hs" that could cause PEA (2 marks) (b) List 4 potential reversible causes from the "4 Ts" that could cause PEA (2 marks) (c) Describe 4 immediate bedside investigations or actions to identify reversible causes (4 marks)

Model Answer:

(a) 4 Hs (0.5 each, max 2):

  • Hypoxia
  • Hypovolaemia
  • Hypokalaemia/Hyperkalaemia
  • Hypothermia

(b) 4 Ts (0.5 each, max 2):

  • Tension pneumothorax
  • Tamponade (cardiac)
  • Toxins
  • Thrombosis (pulmonary embolism or coronary)

(c) Investigations/actions (1 each, max 4):

  • Point-of-care ultrasound/echocardiography - identifies tamponade, PE, hypovolaemia, cardiac activity
  • VBG or ABG for potassium and pH
  • Core temperature measurement for hypothermia
  • Bilateral needle/finger thoracostomy if tension pneumothorax suspected
  • Medication/history review for toxins (from family, paramedics)
  • Point-of-care glucose
  • Chest examination for breath sounds
  • Review IV access and fluid status

Examiner Notes:

  • Accept any reasonable investigation that addresses reversible causes
  • Credit actions (e.g., thoracostomy) as investigations if framed as diagnostic/therapeutic

Question 3 (6 marks)

Stem: A 55-year-old male achieves ROSC after 12 minutes of CPR for VF arrest. He remains comatose.

Question: Outline 6 key components of immediate post-resuscitation care according to ARC guidelines.

Model Answer:

  • Optimise oxygenation targeting SpO2 94-98%, avoiding hyperoxia (1)
  • Maintain normocapnia with PaCO2 35-45 mmHg (1)
  • Obtain 12-lead ECG to identify STEMI - emergent angiography if present (1)
  • Maintain haemodynamic stability with MAP target greater than 65 mmHg (1)
  • Initiate targeted temperature management (32-36 degrees C or avoid fever) (1)
  • ICU admission for ongoing monitoring and care (1)

Examiner Notes:

  • Accept: Avoid hyperthermia, neurological assessment, seizure management, glucose control
  • Accept: Coronary angiography within 2 hours if STEMI, or early if high suspicion
  • Do not accept: Vague answers without specific targets

Question 4 (8 marks)

Stem: Describe the key differences between the ARC/ANZCOR and AHA adult cardiac arrest algorithms.

Question: Outline 4 differences between ARC/ANZCOR and AHA guidelines (2 marks each).

Model Answer:

AspectARC/ANZCORAHA
Adrenaline timing (shockable)After 3rd shock (1 mark)After 2nd shock (1 mark)
Emergency number000 (Australia), 111 (NZ) (1 mark)911 (1 mark)
VasopressinNot included in algorithm (1 mark)Listed as alternative to adrenaline (1 mark)
Sequence emphasisDRSABCD approach (1 mark)CAB approach (1 mark)

Alternative acceptable differences:

  • Different guideline update cycles
  • TTM temperature recommendations vary
  • Atropine removed earlier in ARC

Examiner Notes:

  • Must identify both the ARC and AHA approach for full marks
  • Accept reasonable differences with accurate descriptions

Indigenous Health Considerations

Important Note: Aboriginal, Torres Strait Islander, and Maori Health in Cardiac Arrest:

Epidemiological Disparities:

  • Indigenous Australians experience cardiac arrest at 2-3 times the rate of non-Indigenous Australians [12]
  • Average age at cardiac arrest is 10-15 years younger
  • Higher prevalence of risk factors: ischaemic heart disease, diabetes, hypertension
  • Lower survival rates due to multifactorial causes including access and recognition delays

Barriers to Care:

  • Remote community locations with prolonged response times
  • Variable access to AEDs and trained responders
  • Historical mistrust of healthcare services affecting help-seeking
  • Communication barriers (language, cultural concepts)

Cultural Considerations During Resuscitation:

  • Family presence during resuscitation - many families wish to be present
  • Respect for cultural protocols regarding death and dying
  • Awareness that some communities have specific beliefs about medical interventions
  • Interpreter services should be offered when possible

Post-Arrest Communication:

  • Involve Aboriginal Liaison Officers or cultural consultants
  • Extended family may be involved in decision-making - identify key family members
  • Allow time and space for cultural practices
  • Be aware of "sorry business" and cultural obligations

End-of-Life Considerations:

  • Some communities have specific preferences regarding where death occurs
  • Discuss with family regarding body handling and autopsy
  • Support return to country if appropriate
  • Refer to Indigenous bereavement support services

Practical Steps:

  1. Activate Aboriginal Liaison Service early
  2. Ask family about cultural needs
  3. Allow family presence if desired
  4. Involve community elders if appropriate
  5. Provide culturally appropriate bereavement support

Remote and Rural Considerations

Pre-Hospital Challenges

ChallengeImpactMitigation
Prolonged response timesIncreased downtime, worse outcomesCommunity CPR training, public AED programs
Limited paramedic resourcesSingle responder may arrive firstBystander CPR critical, phone CPR instructions
Transport distancesDelay to definitive careMechanical CPR for transport, retrieval coordination
Communication gapsDelayed notificationTelehealth support, standardised handover

Bystander CPR in Remote Areas

  • Critical importance: May be 30+ minutes before professional help
  • Dispatcher-assisted CPR: 000 operators provide real-time CPR instructions
  • Community training programs: First aid training in remote communities
  • Public AED access: Variable - advocate for AEDs in community centres, schools, sporting facilities

Resource-Limited Resuscitation

When resources are limited:

  • Focus on high-quality CPR (the most important intervention)
  • BVM ventilation acceptable - do not delay for intubation equipment
  • IO access if IV difficult - manual IO needles can be improvised
  • Prioritise adrenaline if only one drug available
  • Consider empiric treatments (thoracostomy, fluids) without imaging

Retrieval and Transport

Royal Flying Doctor Service (RFDS) Considerations:

  • Notify early if ROSC expected or achieved
  • Mechanical CPR enables safe air transport
  • Pre-brief receiving hospital
  • Consider rendezvous points for road-to-air transfer

Termination Decisions:

  • Same principles apply, but consider:
    • Longer transport times meaning different risk-benefit calculation
    • Limited ICU resources at remote hospitals
    • Family presence often greater in small communities
    • Involve remote or retrieval consultation (e.g., TEMSU)

Telemedicine Support

Video-Assisted Resuscitation:

  • Real-time specialist support via telehealth
  • Quality feedback on CPR
  • Guidance on advanced interventions
  • Assistance with termination decisions

Services:

  • TEMSU (Telehealth Emergency Medicine Support Unit) in some states
  • State retrieval services
  • Poison Information Centre (13 11 26)

Key Differences: ARC vs AHA vs ERC

ElementARC/ANZCORAHAERC
Adrenaline timing (shockable)After 3rd shockAfter 2nd shockAfter 3rd shock
Adrenaline timing (non-shockable)ImmediatelyImmediatelyImmediately
Initial rhythm check sequenceDRSABCDCABUnresponsive → Call → CPR
VasopressinNot recommendedAlternative to 1st/2nd adrenalineNot recommended
Amiodarone dose300mg + 150mg300mg + 150mg300mg + 150mg
Lidocaine as alternativeYesYesYes
Atropine for asystoleNo (removed 2010)No (removed 2010)No (removed 2010)
Emergency number000 (Aus) / 111 (NZ)911112/national
Compression rate100-120/min100-120/min100-120/min
Compression depth5-6 cm5-6 cm (at least 5)5-6 cm
TTM target32-36 degrees C32-36 degrees C32-36 degrees C

References

ARC/ANZCOR Guidelines

  1. Australian Resuscitation Council. ANZCOR Guideline 8: Cardiopulmonary Resuscitation. Melbourne: ARC; 2023. Available from: https://resus.org.au

  2. Australian Resuscitation Council. ANZCOR Guideline 11: Adult Advanced Life Support. Melbourne: ARC; 2023.

  3. Australian Resuscitation Council. ANZCOR Guideline 11.1: Medications in Adult Cardiac Arrest. Melbourne: ARC; 2023.

  4. Australian Resuscitation Council. ANZCOR Guideline 11.2: Protocols for Adult Advanced Life Support. Melbourne: ARC; 2023.

  5. Australian Resuscitation Council. ANZCOR Guideline 11.3: Management of Cardiac Arrest Due to Specific Causes. Melbourne: ARC; 2023.

  6. Australian Resuscitation Council. ANZCOR Guideline 14: Post-Resuscitation Care. Melbourne: ARC; 2023.

Epidemiology and Outcomes

  1. Bray JE, Di Palma S, Jacobs I, et al. Trends in the incidence of presumed cardiac out-of-hospital cardiac arrest in Perth, Western Australia, 1997-2010. Resuscitation. 2014;85(6):757-761. PMID: 24642404

  2. Nehme Z, Andrew E, Bernard S, et al. Trends in survival from out-of-hospital cardiac arrests defibrillated by paramedics, first responders and bystanders. Resuscitation. 2019;143:85-91. PMID: 31398401

  3. Beck B, Bray J, Cameron P, et al. Regional variation in the characteristics, incidence and outcomes of out-of-hospital cardiac arrest in Australia and New Zealand: Results from the Aus-ROC Epistry. Resuscitation. 2018;126:49-57. PMID: 29477764

  4. Cartledge S, Saxton D, Finn J, Bray JE. Australia's awareness of cardiac arrest and rates of CPR training: Results from the Heart Foundation's HeartWatch survey. BMJ Open. 2020;10(1):e033265. PMID: 31964662

  5. Aus-ROC Steering Committee. Australian Resuscitation Outcomes Consortium (Aus-ROC) Epistry Annual Report 2022. Melbourne: Monash University; 2023.

Indigenous Health

  1. Brown A, Walsh W. Cardiovascular disease in Indigenous Australians: a manifold problem. Heart Lung Circ. 2019;28(1):40-45. PMID: 30413360

  2. Masterson S, Wright P, O'Donnell C, et al. Urban and rural differences in outcomes from out-of-hospital cardiac arrest: A systematic review. Resuscitation. 2015;94:107-116. PMID: 26092407

  3. Bray JE, Straney L, Barger B, et al. Effect of the COVID-19 pandemic on bystander cardiopulmonary resuscitation in out-of-hospital cardiac arrest. Resuscitation. 2022;172:33-41. PMID: 35032576

Capnography and Monitoring

  1. Touma O, Davies M. The prognostic value of end tidal carbon dioxide during cardiac arrest: A systematic review. Resuscitation. 2013;84(11):1470-1479. PMID: 23871864

  2. Cheskes S, Wudwud A, Turner L, et al. The impact of double sequential external defibrillation for refractory ventricular fibrillation. Resuscitation. 2019;139:275-281. PMID: 31034940

Thrombolysis and Mechanical Causes

  1. Javaudin F, Lascarrou JB, Le Bastard Q, et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest caused by pulmonary embolism increases 30-day survival. Chest. 2019;156(6):1167-1175. PMID: 31374209

ECPR Evidence

  1. Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): A phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807-1816. PMID: 33197396

  2. Kudenchuk PJ, Brown SP, Daya M, et al. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest (ALPS). N Engl J Med. 2016;374(18):1711-1722. PMID: 27043165

Adrenaline Evidence

  1. Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest (PARAMEDIC2). N Engl J Med. 2018;379(8):711-721. PMID: 30021076

  2. Hansen M, Schmicker RH, Newgard CD, et al. Time to Epinephrine Administration and Survival From Nonshockable Out-of-Hospital Cardiac Arrest Among Children and Adults. Circulation. 2018;137(19):2032-2040. PMID: 29511001

Airway Management

  1. Wang HE, Schmicker RH, Daya MR, et al. Effect of a Strategy of Initial Laryngeal Tube Insertion vs Endotracheal Intubation on 72-Hour Survival in Adults With Out-of-Hospital Cardiac Arrest (PART): A Randomized Clinical Trial. JAMA. 2018;320(8):769-778. PMID: 30167701

  2. Benger JR, Kirby K, Black S, et al. Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome (AIRWAYS-2): The AIRWAYS-2 Randomized Clinical Trial. JAMA. 2018;320(8):779-791. PMID: 30167700

Mechanical CPR

  1. Rubertsson S, Lindgren E, Smekal D, et al. Mechanical chest compressions and simultaneous defibrillation vs conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: The LINC randomized trial. JAMA. 2014;311(1):53-61. PMID: 24240611

  2. Perkins GD, Lall R, Quinn T, et al. Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial. Lancet. 2015;385(9972):947-955. PMID: 25467566

Post-Resuscitation Care

  1. Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2). N Engl J Med. 2021;384(24):2283-2294. PMID: 34133859

  2. Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary Angiography after Cardiac Arrest without ST-Segment Elevation (COACT). N Engl J Med. 2019;380(15):1397-1407. PMID: 30883057

  3. Belohlavek J, Smalcova J, Rob D, et al. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest (Prague OHCA): A Randomized Clinical Trial. JAMA. 2022;327(8):737-747. PMID: 35103762

International Guidelines

  1. Soar J, Bottiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: Adult advanced life support. Resuscitation. 2021;161:115-151. PMID: 33773835

  2. Panchal AR, Bartos JA, Cabanas JG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 Suppl 2):S366-S468. PMID: 33081529

Prognostication

  1. Sandroni C, D'Arrigo S, Cacciola S, et al. Prediction of good neurological outcome in comatose survivors of cardiac arrest: a systematic review. Intensive Care Med. 2022;48(4):389-413. PMID: 35254471

  2. Nolan JP, Sandroni C, Bottiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. Resuscitation. 2021;161:220-269. PMID: 33773826

Australian-Specific Studies

  1. Nehme Z, Andrew E, Bray JE, et al. The significance of pre-arrest factors in out-of-hospital cardiac arrests witnessed by emergency medical services: a report from the Victorian Ambulance Cardiac Arrest Registry. Resuscitation. 2015;88:35-42. PMID: 25534696

  2. Bray JE, Bernard S, Cantwell K, et al. The association between systemic temperature and out-of-hospital cardiac arrest outcomes. Resuscitation. 2018;124:17-23. PMID: 29309816

  3. Stub D, Bernard S, Pellegrino V, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015;86:88-94. PMID: 25281189

CPR Quality

  1. Meaney PA, Bobrow BJ, Mancini ME, et al. Cardiopulmonary resuscitation quality: Improving cardiac resuscitation outcomes both inside and outside the hospital. Circulation. 2013;128(4):417-435. PMID: 23801105

  2. Idris AH, Guffey D, Aufderheide TP, et al. Relationship between chest compression rates and outcomes from cardiac arrest. Circulation. 2012;125(24):3004-3012. PMID: 22623717

  3. Stiell IG, Brown SP, Nichol G, et al. What is the optimal chest compression depth during out-of-hospital cardiac arrest resuscitation of adult patients? Circulation. 2014;130(22):1962-1970. PMID: 25252721

Special Circumstances

  1. Truhlář A, Deakin CD, Soar J, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances. Resuscitation. 2015;95:148-201. PMID: 26477412

  2. Lavonas EJ, Drennan IR, Gabrielli A, et al. Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18 Suppl 2):S501-S518. PMID: 26472998

Team Performance

  1. Hunziker S, Johansson AC, Tschan F, et al. Teamwork and leadership in cardiopulmonary resuscitation. J Am Coll Cardiol. 2011;57(24):2381-2388. PMID: 21658556

  2. Fernandez Castelao E, Russo SG, Cremer S, et al. Positive impact of crisis resource management training on no-flow time and team member verbalisations during simulated cardiopulmonary resuscitation: a randomised controlled trial. Resuscitation. 2011;82(10):1338-1343. PMID: 21757266

Frequently asked questions

Quick clarifications for common clinical and exam-facing questions.

What is the difference between ARC and AHA algorithms for adrenaline timing?

ARC recommends adrenaline after the 3rd shock in shockable rhythms, whereas AHA recommends after the 2nd shock. For non-shockable rhythms, both recommend immediate adrenaline administration.

What is the target compression rate in ARC guidelines?

100-120 compressions per minute with depth of 5-6 cm in adults, allowing full chest recoil between compressions.

When should amiodarone be given in VF/pVT?

300mg IV/IO after the 3rd shock, with a second dose of 150mg after the 5th shock if VF/pVT persists.

What are the indications for ECPR?

Consider ECPR for refractory shockable rhythm, age typically under 70, witnessed arrest with good-quality CPR, reversible cause suspected, and available expertise/resources.

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

Differentials

Competing diagnoses and look-alikes to compare.

Consequences

Complications and downstream problems to keep in mind.